A Randomized Trial of PHOTOdynamic Surgery in Non–Muscle-Invasive Bladder Cancer
- 27 September 2022
- journal article
- research article
- Published by Massachusetts Medical Society in NEJM Evidence
- Vol. 1 (10)
- https://doi.org/10.1056/evidoa2200092
Abstract
PDD or WL Resection of Tumors in NMIBCIn this open-label trial, patients with intermediate- or high-risk non–muscle-invasive bladder cancer at diagnosis were randomly assigned to photodynamic diagn... AbstractBackgroundRecurrence of non–muscle-invasive bladder cancer (NMIBC) is common after transurethral resection of bladder tumor (TURBT). Photodynamic diagnosis (PDD) provides better diagnostic ...This publication has 26 references indexed in Scilit:
- Hexyl Aminolevulinate–Guided Fluorescence Cystoscopy in the Diagnosis and Follow-up of Patients with Non–Muscle-invasive Bladder Cancer: A Critical Review of the Current LiteratureEuropean Urology, 2013
- EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 UpdateEuropean Urology, 2011
- Photodynamic diagnosis of bladder cancer compared with white light cystoscopy: Systematic review and meta-analysisInternational Journal of Technology Assessment in Health Care, 2011
- Mechanisms of recurrence of Ta/T1 bladder cancerThe Annals of The Royal College of Surgeons of England, 2010
- An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder CancerEuropean Urology, 2009
- Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC TrialsEuropean Urology, 2006
- The economic consequences of prostate and bladder cancer in the UKBJU International, 2004
- Classification of Surgical ComplicationsAnnals of Surgery, 2004
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990